APA (7th ed.) Citation

Wolchok, J. D., Hodi, F. S., & Larkin, J. (2025). Nivolumab plus Ipilimumab in Advanced Melanoma: THE AUTHORS REPLY. New England Journal of Medicine, 392(12), 1246. https://doi.org/10.1056/NEJMc2501311

Chicago Style (17th ed.) Citation

Wolchok, Jedd D., F. Stephen Hodi, and James Larkin. "Nivolumab Plus Ipilimumab in Advanced Melanoma: THE AUTHORS REPLY." New England Journal of Medicine 392, no. 12 (2025): 1246. https://doi.org/10.1056/NEJMc2501311.

MLA (9th ed.) Citation

Wolchok, Jedd D., et al. "Nivolumab Plus Ipilimumab in Advanced Melanoma: THE AUTHORS REPLY." New England Journal of Medicine, vol. 392, no. 12, 2025, p. 1246, https://doi.org/10.1056/NEJMc2501311.